首页 | 本学科首页   官方微博 | 高级检索  
检索        

左主干病变冠脉搭桥患者围术期及中长期临床效果分析
作者姓名:Chen W  Zhang JQ  Gan HL  Wang SX  Kong QY  Zheng SH  Bo P  Huang GH
作者单位:首都医科大学附属北京安贞医院北京心肺血管疾病研究所心脏外科,100029
摘    要:目的 评价冠状动脉左主干狭窄(LMS)行冠状动脉搭桥术(CABG)围术期及中长期疗效,并分析术前应用他汀类药物对围术期疗效的影响.方法 回顾性分析1998年1月至2008年3月北京安贞医院收治626例LMS行CABG围术期疗效资料及中长期随访结果,按患者在入院前是否服用他汀类药物(持续2周以上)将LMS患者分为服用他汀...

关 键 词:冠心动脉疾病  手术期间  他汀类药物

Early, middle and long-term clinical outcomes of coronary artery bypass grafting for left main coronary stenosis
Chen W,Zhang JQ,Gan HL,Wang SX,Kong QY,Zheng SH,Bo P,Huang GH.Early, middle and long-term clinical outcomes of coronary artery bypass grafting for left main coronary stenosis[J].National Medical Journal of China,2011,91(15):1016-1021.
Authors:Chen Wei  Zhang Jian-qun  Gan Hui-Li  Wang Sheng-xun  Kong Qing-yu  Zheng Si-hong  Bo Ping  Huang Guo-hui
Institution:Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University & Beijing Institute of Heart, Lung & Vascular Diseases, Beijing 100029, China.
Abstract:Objective To evaluate the early, middle and long-term clinical outcomes of coronary artery bypass grafting (CABG) for a special subset of left main coronary stenosis (LMS). Methods A total of 626 LMS patients, recruited at our hospital between January 1998 and March 2008, were classified them into the statin therapy group ( Group A, n = 322) or the non-statin therapy group ( Group B, n = 304 )according to whether or not taking statins pre-operatively. Then their clinical data were retrospectively analyzed. Results The inhospital mortality was 4. 31% ( n = 27 ). And the mortality was 1.90% ( n = 6) for Group A and 6. 91% for Group B ( n = 21 ) (x2 test, x2 = 9. 642, P = 0. 002 ). Preoperative statin therapy could lower the all-cause mortality rate ( 1.90% vs 6. 91%, P = 0. 002), the prevalence of new atrial fibrillation or flutter ( 14. 69% vs 19. 61%, P = 0. 016, x2 = 5. 780 ) and disabling stroke ( 2. 50% vs4. 58%, P =0. 047, x2 =3.94). Among 599 CABG survivors, 565 cases (94. 3% ) were actually followed up with a mean duration of 55.5 ±26. 1 months (range:2 -98). During the follow-up period, there were 29(4.63%) cardiac events, including 12 deaths and 17 myocardial infarctions. There were 43 (7. 18% ) cases with relapsing angina pectoris. The univariate analysis showed that emergency procedure, abnormal C-reactive protein (CRP), abnormal troponin I (TnI), complicated LMS pathology, preoperative IABP (intra-aortic balloon pump) support, preoperative cardiac arrest, preoperative history of myocardium infarction and no preoperative statin therapy were the risk factors for perioperative death while complicated LMS pathology,preoperative IABP support, preoperative cardiac arrest, preoperative myocardium infarction and no preoperative statin therapy were the risk factor for late cardiac events. The multivariate binary logistic regression showed that emergency procedure, preoperative IABP support, no preoperative statin therapy and preoperative IABP support were independent predictors for peri-operative death. And preoperative IABP support, preoperative cardiac arrest, no preoperative statin therapy and complicated LMS pathology were independent predictors for late cardiac events. There was no statistical significance in inhospital mortality between on pump CABG and OPCAB (off pump coronary artery bypass). Conclusion The CABG procedure for LMS carries a relative high mortality. However preoperative statin therapy may offer such protective effects as lowering the all-cause mortality rate and reducing the prevalence of new atrial fibrillation or flutter and disabling stroke.
Keywords:Coronary disease  Intraoperative period  Statins
本文献已被 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号